ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

SABSW SAB Biotherapeutics Inc

0.035
0.0046 (15.13%)
01 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
SAB Biotherapeutics Inc SABSW 나스닥 주식 인수형 워런트
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0046 15.13% 0.035 08:50:01
개장가 저가 고가 종가 전일 종가
0.035 0.035 0.035 0.035 0.0304
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202420:15GLOBESAB Biotherapeutics Provides SAB-142 Trial Update
08/04/202420:15GLOBESAB Biotherapeutics to Present at INNODIA Annual Meeting
04/04/202420:15GLOBESAB Biotherapeutics to Present at the Needham Virtual..
29/03/202420:15GLOBESAB Biotherapeutics Reports Full Year 2023 Operating and..
25/03/202423:15GLOBESAB Biotherapeutics Announces Clinical Partnership with..
23/02/202422:00GLOBESAB Biotherapeutics to Present at the BIO CEO & Investor..
08/02/202422:00GLOBESAB Biotherapeutics to Present at the Oppenheimer..
02/02/202421:30GLOBESAB Biotherapeutics Announces Executive Leadership Change
24/01/202407:58GLOBESAB Biotherapeutics Regains Compliance with Nasdaq Minimum..
03/01/202406:30GLOBESAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
29/11/202321:30GLOBESAB Biotherapeutics Announces Commencement of the HUMAN..
20/11/202321:30GLOBESAB Biotherapeutics Appoints Katie Ellias to the Board of..
14/11/202321:30GLOBESAB Biotherapeutics Announces Completion of $67.1 Million..
14/11/202321:15GLOBESAB Biotherapeutics Announces Q3 2023 Financial Results and..
09/11/202321:30GLOBESAB Biotherapeutics to Present at Piper Sandler Healthcare..
24/10/202320:30GLOBESAB Biotherapeutics Appoints Michael G. King Jr. as Chief..
19/10/202320:30GLOBESAB Biotherapeutics Receives Australian Approval to Commence..
05/10/202320:30GLOBESAB Biotherapeutics Approves Appointment of Andrew Moin to..
02/10/202320:30GLOBESAB Biotherapeutics Announces Private Placement of up to..
21/08/202321:30GLOBESAB Biotherapeutics Provides Company Update for Q2..
21/06/202321:30GLOBESAB Biotherapeutics Presents Positive IND-Enabling GLP..
30/05/202321:30GLOBESAB Biotherapeutics to Present Novel Human IgG Platform with..
19/05/202321:30GLOBESAB Biotherapeutics Presents Virtual 2023 R&D Day Portfolio..
16/05/202321:30GLOBESAB Biotherapeutics Provides Company Update for Q1 2023..
12/05/202321:30GLOBESAB Biotherapeutics Announces First Publication of Promising..
09/05/202321:30GLOBESAB Biotherapeutics Announces Progress on U.S. FDA’s Phased..
04/05/202321:30GLOBESAB Biotherapeutics Presents Positive Phase 1 and 2a Data..
04/05/202306:00GLOBESAB Biotherapeutics to Present at Sidoti Virtual Investor..

최근 히스토리

Delayed Upgrade Clock